X-Received: by 2002:a05:620a:458d:b0:6b2:49a1:dc3b with SMTP id bp13-20020a05620a458d00b006b249a1dc3bmr13609324qkb.766.1656934010637;
Mon, 04 Jul 2022 04:26:50 -0700 (PDT)
X-Received: by 2002:a05:6870:ea90:b0:101:fb35:883d with SMTP id
s16-20020a056870ea9000b00101fb35883dmr17033976oap.23.1656934010355; Mon, 04
Jul 2022 04:26:50 -0700 (PDT)
Path: i2pn2.org!i2pn.org!weretis.net!feeder6.news.weretis.net!news.misty.com!border2.nntp.dca1.giganews.com!nntp.giganews.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: alt.os.linux.slackware
Date: Mon, 4 Jul 2022 04:26:50 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=178.170.183.64; posting-account=XSirDwoAAAADOU56A24BSwoltzp-uhEo
NNTP-Posting-Host: 178.170.183.64
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <a12db2d9-3795-433a-adcd-26a2854abebbn@googlegroups.com>
Subject: (PDF) Principles of Anticancer Drug Development by Elizabeth Garrett-Mayer
From: hesterho...@gmail.com (hester holt)
Injection-Date: Mon, 04 Jul 2022 11:26:50 +0000
Content-Type: text/plain; charset="UTF-8"
Lines: 1